Evidence map›Paper›PMID 41340152›Full record

ArticleJournal of neuroinflammation2025

High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease.

Christopher L Cardona, Lai Wei, Joonwon Kim, Ellen Angeles, Gunjandeep Singh, Shiye Chen, Ronak Patel, Nkechime Ifediora, Peter Canoll, Andrew F Teich and 3 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Christopher L Cardona *Department of Pathology and Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY, USA.
Lai Wei *Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Joonwon Kim *Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Ellen Angeles *Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Taub Institute), CUIMC, New York, NY, USA.
Gunjandeep SinghTaub Institute for Research on Alzheimer's Disease and the Aging Brain (Taub Institute), CUIMC, New York, NY, USA.
Shiye ChenDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Ronak PatelTaub Institute for Research on Alzheimer's Disease and the Aging Brain (Taub Institute), CUIMC, New York, NY, USA.
Nkechime IfedioraDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY, USA.
Peter CanollDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY, USA.
Andrew F TeichDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY, USA.
Gunnar HargusDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY, USA.
Alejandro ChavezDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA. chavez2@health.ucsd.edu.
Andrew A SproulDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center (CUIMC), New York, NY, USA. aas2003@cumc.columbia.edu.

Funding

Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ying Wei · 2020 to 2026
$30.1M
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patientsR01AG073360 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MCKHANN, GUY M, TEICH, ANDREW FRANKLIN · 2021 to 2025
$4.2M
Methods to Rapidly Explore Combinatorial Diversity and Their Application to CRISPR-Cas9 SystemsDP2NS131566 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Alejandro Chavez · 2022 to 2026
$2.4M
Elucidating the Role of Microglia and Neurotrophin Receptor p75 on Neuronal Degeneration in Frontotemporal DementiaK08NS116166 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARGUS, GUNNAR · 2021 to 2025
$968k
Developing a microfluidic human neurovascular unit system to investigate genetic and age-related risk factors in Alzheimer's diseaseR01AG078352 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Dritan Agalliu, Andrew Alexander Sproul · 2025 to 2026
$837k
NIA NIH HHS P30 AG066462NIA NIH HHS P30AG066462-02NIA NIH HHS R01 AG073360NIA NIH HHS R01AG073360NIA NIH HHS R01 AG078352NIH HHS DP2NS131566-02NINDS NIH HHS DP2 NS131566NINDS NIH HHS K08 NS116166Thompson Family Foundation TAME-AD
6 · The paper itself

Abstract

Greater than a hundred genetic risk factors for Alzheimer’s disease (AD) have been identified by genome-wide association studies (GWAS), many of which are primarily expressed in microglia. However, the pathogenic role for most of them remains unclear. We sought to assess at scale how AD GWAS hits influence human microglial inflammatory responses. Thus, we conducted CRISPR inhibition (CRISPRi) screens of 119 AD GWAS hits in hiPSC-derived microglia (iMGLs), with reactive oxygen species (ROS) produced in response to the viral mimic poly(I:C) as a readout. Top hits that either decreased or increased ROS in response to poly(I:C) when knocked down were then interrogated in CROP-seq experiments, where CRISPRi was combined with single cell RNA-sequencing (scRNA-seq). These analyses identified 9 unique microglial clusters, including a poly(I:C)-driven inflammatory cluster (2). Emerging evidence supports a pathogenic role of viral infections in AD and our scRNA-seq showed significant overlap with AD-relevant microglial clusters. Knockdown (KD) of two hit genes, MS4A6A and EED, which lead to high levels of ROS in the presence of poly(I:C), increased the proportion of inflammatory cluster 2 cells and led to functionally related changes in gene expression. In addition, KD of MS4A6A reduced the proportion of iMGLs in the disease-associated microglia (DAM) cluster under all conditions, suggesting that MS4A6A may modulate the DAM response. In contrast, KD of hit genes, INPP5D or RABEP1 which led to low levels of ROS in the presence of poly(I:C), did not significantly affect the proportion of cells in inflammatory cluster 2 but rather shaped the inflammatory response. This included upregulation of a poly(I:C)-independent HLA inflammatory cluster (6) by INPP5D KD under all conditions. Despite INPP5D or RABEP1 being involved in disparate biological processes, their perturbation led to similar changes in gene expression, which included changes in genes related to metabolism such as oxidative phosphorylation, suggesting a shared conversion point by which AD GWAS hits affect cell state. Overall, our data begin to elucidate the functional roles played by various AD GWAS hits, including how they regulate and shape inflammatory responses such as those observed in AD.

Indexed as

Alzheimer DiseaseInflammationMicrogliaNeuroinflammatory DiseasesGenome-Wide Association StudyHumansReactive Oxygen SpeciesReactive Oxygen SpeciesAlzheimer’s diseaseCRISPRi screenCROP-seqEEDhiPSCsInflammationINPP5DMicrogliaMS4A6ARABEP1

Identifiers

PMID41340152
PMCPMC12729107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.